These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24147742)

  • 21. Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders.
    Ressler KJ
    Am J Psychiatry; 2020 Mar; 177(3):214-222. PubMed ID: 32114783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders.
    McNally RJ
    Clin Psychol Rev; 2007 Jul; 27(6):750-9. PubMed ID: 17292521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fear extinction and relapse: state of the art.
    Vervliet B; Craske MG; Hermans D
    Annu Rev Clin Psychol; 2013; 9():215-48. PubMed ID: 23537484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fear conditioning in adolescents with anxiety disorders: results from a novel experimental paradigm.
    Lau JYF; Lissek S; Nelson EE; Lee Y; Roberson-Nay R; Poeth K; Jenness J; Ernst M; Grillon C; Pine DS
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):94-102. PubMed ID: 18174830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Getting Better with Age? A Review of Psychophysiological Studies of Fear Extinction Learning Across Development.
    Stenson AF; France JM; Jovanovic T
    Curr Top Behav Neurosci; 2023; 64():213-236. PubMed ID: 37651043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning About Safety: Conditioned Inhibition as a Novel Approach to Fear Reduction Targeting the Developing Brain.
    Odriozola P; Gee DG
    Am J Psychiatry; 2021 Feb; 178(2):136-155. PubMed ID: 33167673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental pathways in youth anxiety disorders: potential mechanisms for (mal)adapting to crises and improving treatment - a commentary on Klein et al. (2023).
    Roesmann K; Asbrand J
    J Child Psychol Psychiatry; 2024 Feb; 65(2):229-232. PubMed ID: 37815123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Core Mechanisms of Cognitive Behavioral Therapy for Anxiety and Depression: A Review.
    Powers MB; de Kleine RA; Smits JAJ
    Psychiatr Clin North Am; 2017 Dec; 40(4):611-623. PubMed ID: 29080589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a cognitive-learning formulation of youth anxiety: A narrative review of theory and evidence and implications for treatment.
    Waters AM; Craske MG
    Clin Psychol Rev; 2016 Dec; 50():50-66. PubMed ID: 27693665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How can neurobiology of fear extinction inform treatment?
    Craske MG; Sandman CF; Stein MB
    Neurosci Biobehav Rev; 2022 Dec; 143():104923. PubMed ID: 36280184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translational approaches to anxiety: focus on genetics, fear extinction and brain imaging.
    Erhardt A; Spoormaker VI
    Curr Psychiatry Rep; 2013 Dec; 15(12):417. PubMed ID: 24234873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The key role of extinction learning in anxiety disorders: behavioral strategies to enhance exposure-based treatments.
    Pittig A; van den Berg L; Vervliet B
    Curr Opin Psychiatry; 2016 Jan; 29(1):39-47. PubMed ID: 26575298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitional and translational studies of risk for anxiety.
    Casey BJ; Ruberry EJ; Libby V; Glatt CE; Hare T; Soliman F; Duhoux S; Frielingsdorf H; Tottenham N
    Depress Anxiety; 2011 Jan; 28(1):18-28. PubMed ID: 21225849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention avoidance of the threat conditioned stimulus during extinction increases physiological arousal generalisation and retention.
    O'Malley KR; Waters AM
    Behav Res Ther; 2018 May; 104():51-61. PubMed ID: 29549751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurobiology of anxiety disorders and implications for treatment.
    Garakani A; Mathew SJ; Charney DS
    Mt Sinai J Med; 2006 Nov; 73(7):941-9. PubMed ID: 17195879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders.
    Otto MW; Basden SL; Leyro TM; McHugh RK; Hofmann SG
    CNS Spectr; 2007 Jan; 12(1):51-6, 59-61. PubMed ID: 17192764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Action in Exposure Therapy.
    Knowles KA; Tolin DF
    Curr Psychiatry Rep; 2022 Dec; 24(12):861-869. PubMed ID: 36399234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.
    VanElzakker MB; Dahlgren MK; Davis FC; Dubois S; Shin LM
    Neurobiol Learn Mem; 2014 Sep; 113():3-18. PubMed ID: 24321650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rethinking avoidance: Toward a balanced approach to avoidance in treating anxiety disorders.
    Hofmann SG; Hay AC
    J Anxiety Disord; 2018 Apr; 55():14-21. PubMed ID: 29550689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rodent models of impaired fear extinction.
    Singewald N; Holmes A
    Psychopharmacology (Berl); 2019 Jan; 236(1):21-32. PubMed ID: 30377749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.